Dustin J Little

13PUBLICATIONS
19CO-AUTHORS
Time-series analysisCardiology (incl. cardiovascular diseases)Predictive and prognostic markersNutritional epidemiologyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 26, 2026
A Hierarchical Composite Endpoint for Chronic Kidney Disease Progression in Patients with Focal Segmental Glomerulosclerosis.

Hiddo J L Heerspink, Dustin J Little, Samvel B Gasparyan

|Oct 24, 2023
Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression.

Hiddo J L Heerspink, Niels Jongs, Patrick Schloemer

|Oct 09, 2023
Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review.

Dustin J Little, Samvel B Gasparyan, Patrick Schloemer

|Oct 17, 2022
Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD.

Pablo E Pergola, Chaim Charytan, Dustin J Little

|Apr 01, 2022
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.

Steven Fishbane, Carol A Pollock, Mohamed El-Shahawy

|Aug 07, 2021
Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials.

Robert Provenzano, Lynda Szczech, Robert Leong

Pageof 3

Frequent Collaborators

5 joint publications

Hiddo J L Heerspink

4 joint publications

Samvel B Gasparyan

4 joint publications

Niels Jongs

3 joint publications

Meike Brinker